Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
about
Recombinant Poliovirus for Cancer Immunotherapy.Recurrent Glioblastoma Treated with Recombinant Poliovirus.Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer CellsRecombinant poliovirus for cancer immunotherapyHigh expression of GALNT7 promotes invasion and proliferation of glioma cells
P2860
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Validation of an Immunohistoch ...... eceptor, in Malignant Gliomas.
@en
type
label
Validation of an Immunohistoch ...... eceptor, in Malignant Gliomas.
@en
prefLabel
Validation of an Immunohistoch ...... eceptor, in Malignant Gliomas.
@en
P2093
P2860
P1476
Validation of an Immunohistoch ...... eceptor, in Malignant Gliomas.
@en
P2093
Eric S Lipp
Hailan Piao
Jeffrey D Bryant
Kathryn Perkinson
Matthias Gromeier
Michaela Lefaivre
Stephen T Keir
Vidyalakshmi Chandramohan
P2860
P356
10.5858/ARPA.2016-0580-OA
P577
2017-08-22T00:00:00Z